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Testing Their Metal
Metals continually rank at the top of the
U.S. Environmental Protection Agency's
annual list of agents that pose the greatest
hazard to the people of the United States.
Metals aren't going away, either. They do
not biodegrade, and they often concentrate
in human and animal cells and tissue.
Many metals are known human and ani-
mal carcinogens, while many others are
suspected to play a role in cancer. Little is
known, however, about the mechanisms
by which metals cause cancer.
The Inorganic Carcinogenesis Section
(ICS) at the NIEHS, headed by toxicologist
Michael Waalkes, is devoted to studying the
carcinogenic mechanisms ofmetals. The sec-
tion is a collaborative effort between the
laboratory of Pharmacology and Chemistry
at the NIEHS and the Laboratory of
Comparative Carcinogenesis at the National
Cancer Institute (NCI). The section was
previously located at the NCI and was
moved to the NIEHS in 1996. Waalkes,
who served as chief of the section at the
NCI, says he was sent from that agency to
act as a bridge and stimulate collaboration
between the two institutes. Says Waalkes,
"We study how tolerance develops to these
metals. Sometimes they are stored, occasion-
ally they are metabolized. It's a totally differ-
ent world than [studying] organics."
The ICS is specifically focusing on
studying three inorganics: arsenic, cadmi-
um, and lead. Arsenic and cadmiuim are
classified as known human carcinogens by
the International Agency for Research on
Cancer and the National Toxicology Pro-
gram, and lead is considered a possible
human carcinogen. Ironically, despite their
carcinogenic activity, arsenic and cadmium
also have antitumor potential, and arsenic
is already used in chemotherapy for specific
tumors. The ICS is also studying this
capacity.
"All of us are
exposed to these metals;
it's just a fact of life,"
says Waalkes. "It's
important for us to
understand the mecha-
nisms by which they are
carcinogenic, in order to




than a century, scientists
have known that arsenic
is a human carcinogen,
but its mechanism of
action is still unknown.
It has been associated
with lung, skin, bladder, Flame re;
and liver tumors. Knowles
Arsenic is a by-product ter, whict
of many industrial
processes, including semiconductor manu-
facturing, petroleum refining, and mining
and smelting operations. Arsenic is com-
monlIv found in nature and is released
from soil and rock erosion into water.
High levels of arsenic are prevalent in
drinking water in many areas, including
the southwestern United States, Michigan,
and southern Asia. Currently, there is con-
troversy about what level of arsenic in
drinking water is safe, as the health effects
of low levels of arsenic exposure are
unclear.
Waalkes says arsenic's mechanism of
carcinogenic action is difficult to study. It
is the only known human carcinogen that
has not been definitely shown to cause
tumors by itselfin laboratory animals. This
indicates that humans may be more sensi-
tive to arsenic than animals.
Waalkes and colleagues had a break-
through finding when they used a cell
model system to test a hypothesis about
In the case of cadmium. A micrograph of the lung of a rat injected with cadmium shows a metastatic
fibrosarcoma on the right. On the left are normal cells.
aders. Toxicologist Michael Waalkes and lab technician Tammy
examine the flame from an atomic absorption spectrophotome-
h is used to measure the levels of metals in biological samples.
the potential irole of methylation inl
arsenics mechanism of carcillogenic
action. When arsenic is mctabolized, ir
undergoes cnzymatic meths lationl, a
process in which methyl groups are added
to the metal. This process is thought to aidi
in detoxifying the metal.
DNA is also typically methNylated in
order to serve in regulating the expression
of a variety of genes, includinig oncogenes.
However, DNA methylation requires the
same methyl donor that is consumed in
arsenic methylation. When the meth+
donor is not available, the lDNA is unider-
methylated, or hypomethylated, and i's
therefore unable to properly regulate gene
expression. Therefore, arsenic appears to
indirectly induce aberrant gene expression
through the induction of DNA
hypomethylation. DNA hxypomethylatioll
is thought to constitute an earls event in
some cancers and has been associated with
many types of tumors, including those (of
the liver and colon.
Waalkes and colleagues tested this
hypothesis and successfully confirmed that
malignant transformation occurred in ctil-
tured epithelial liver cells of r-ats.
Malignant transformation was confirmed
by the production oftumors when the cells
were injected into mice. This study) was
published in the 30 September 1997 iSSuC
of the Proceedings ofthe NationalAcademy
ofSciences. The researchers are currently
investigating gene activation during
arsenic-induced malignant transformation
in this cultured cell system. They are also
studying the carcinogenic effects of arsenic
in mice in several specialized systems,
including transplacental exposure.
Cadmium. Although cadmium is cai-
ciinogenic, it is. not thought tO he hibels
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mutagenic. How cadmium causes cancer is
still unknown, but Waalkes and colleagues
are making significant strides in unraveling
the mystery of this mechanism. Cadmium
is used in electroplating, paints, and cad-
mium-nickel batteries.
In a significant 1998 study, ICS
researchers found that cadmium appears to
block programmed cell death, or apoptosis.
By stopping this process, cells that would
otherwise die, including those with dam-
aged DNA, may continue to live and
divide. This probably results in increasing
numbers ofcells with altered DNA, which
can eventually lead to the development of
tumors. The researchers believe that the
suppression of apoptosis may be a signifi-
cant aspect of cadmium's carcinogenic
mechanism. The study was published in
the 22 May 1998 issue of the Journal of
Toxicology andEnvironmentalHealth.
Some research suggests that cadmium
exposure may be associated with human
prostate cancer. Both the incidence and
mortality ofprostate cancer is increasing in
the United States. Age-adjusted mortality
rates from prostate cancer have increased
by nearly 30% over the last 35 years. The
exact cause of prostate cancer is still
unknown, but demographic studies suggest
that environmental factors, perhaps includ-
ing exposure to cadmium, may playa role.
Waalkes and colleagues are working to
develop models of cadmium-induced
prostate cancers. In several studies, they
discovered that cadmium exposure was
associated with proliferative lesions and
cancers of the rat prostate. One recent
study has been submitted to Toxicological
Sciencesfor publication.
Waalkes says his team will continue to
look at model systems of the human
prostate, and they plan to test a hypothesis
that cadmium may modify proliferation in
the prostate epithelial cells by altering the
way that testosterone interacts with its
receptor.
Lead. Lead is considered one of the
single most hazardous substances to the
population of the United States due to its
neurotoxicity, particularly in children, says
Waalkes. However, its carcinogenic poten-
tial remains controversial. Lead has accu-
mulated in houses and the environment
due to its use for many years in paint and
gasoline.
In animals, lead was previously thought
to be carcinogenic in the kidney as a result
of nongenotoxic mechanisms involving
chronic nephropathy. This process occurs
when DNA, in response to a toxic stimu-
lus, attempts to repair damage caused by
the toxicant. The repair attempts cause
increases in the rate of cell division, which
in turn increases the incidence of random
errors in DNA. These errors have the
potential to lead to the development of
tumors.
However, ICS researchers examined
the carcinogenicity ofshort-term gestation-
al and lactational lead exposure in mice
and found that lead was clearly a renal car-
cinogen in treated offspring. In what
Waalkes calls "a major breakthrough," the
team found that lead-induced renal tumors
occurred long after short-term exposure
and in the absence ofchronic neuropathy.
The researchers say this indicates that lead
may be a specific renal carcinogen. These
findings were published in the 15
November 1995 issue of Cancer Research.
Waalkes adds that lead was one ofthe first
inorganic substances shown to be a
transplacental carcinogen in rodents.
Future studies will help elucidate the
potential genotoxic mechanisms of lead,
Waalkes says.
Future plans for the ICS also include
the study of metallothionein, a metal-
binding protein that is involved in protec-
tion against metal toxicity. ICS researchers
have conducted studies on the role ofmet-
allothionein in the antitumor effects of
cadmium. They plan to further investigate
metallothionein's role in arsenic-induced
malignant transformation and in lead-
induced renal tumors.
BrandyE. Fisher
Ames Awarded Medal of Honor
Bruce Ames, a professor ofbiochemistry and molecular biology and director ofthe NIEHS
Center at the University ofCalifornia at Berkeley, was awarded the nation's top scientific
honor-the National Medal ofScience. Ames was given the award
by President Clinton on 27April 1999.
The National Medal ofScience was established in 1959 and is
given annually to individuals for outstanding contributions to the s>
knowledge base ofthe physical, biological, mathematical, engineer- ,
ing, social, and behavioral sciences. The National Science
Foundation administers theprogram forthePresident.
Ames was chosen for work that "changed the direction ofbasic
and applied research on mutation, cancer, and aging," according to
a press release from the White House Office of Science and
Technology Policy. Ames says, "I am interested in what damages
DNA and how to prevent it." He says his work indicates that nor-
mal metabolism, bad diet, and smoking are the main causes ofcan-
cerandotherdiseases associated with aging.
Ames has conducted extensive research on how micronutrient
deficiencies affect health. Research indicates that the quarter ofthe
population that eats the fewest fruits and vegetables has about dou-
ble the cancer rates for most types ofcancer when compared to the quarter with the highest
intake. Approximately 80% ofU.S. children and adolescents and 68% ofadults do not eat
the recommended five portions offruits andvegetables perday. Ames has focused his research
on the mechanisms bywhich micronutrient deficiencies cause DNAdamage, which appear to
besimilarto the cancer-causing mechanisms ofradiation and manychemicals.
Ames investigated folate deficiency, which occurs in approximately 10% ofthe popula-
tion and in a much higher percentage among the poor. He discovered that folate deficiency
causes extensive incorporation ofuracil into human DNA, which leads to breaks in chro-
mosomes. This mechanism is the likely cause of the increased cancer risk associated with
folate deficiency, Ames says, and maycontribute to cognitive defects, which have been asso-
ciatedwith lowfolate intake. Ames says his current research suggests that deficiencies ofvit-
amins B-12 and B-6 also cause high uracil and chromosome breaks.
Ames has also conducted extensive research on oxidants and antioxidants. The oxidant
by-products ofnormal energymetabolism (superoxide, hydrogen peroxide, andhydroxyl radi-
cal) are the same mutagens produced by radiation. Deficiencies ofdietary antioxidants, such
as vitamins C and E, mimic radiation exposure. Ames found that oxidative damage to DNA
and other macromolecules appears to play a major role in aging and degenerative diseases
associated with aging, induding cancer.
Ames was also recognized for his early contribution to the field ofgenetic toxicology. In
the late 1960s, he developed a simple, inexpensive bacterial test, known as the Ames test, for
environmental and natural mutagens.
Says Ames, "It's nice when people appreciate you and your work." He plans to persist at
unraveling themysteries ofDNAdamage, saying, "I'm still busilyworking in thelab."
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